Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
21
Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE(R) (bortezomib) for Injection for patients with a common type of lymphoma. The study will examine previously untreated patients with a genomically defined subtype of lymphoma called non-germinal center B- cell-like (non-GCB) diffuse large B-cell lymphoma.
British medical scientists say they've demonstrated that unusual metal compounds can be used to form effective cancer drugs. Researchers at the University of Leeds and the University of Warwick said such metals can form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs.
Peregrine Pharmaceuticals, Inc. today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.
Being informed on prevention is key to good health; unfortunately today, by some, prevention is being diluted into what it is not. A few years ago, the term 'prevention' was rarely part of the vocabulary in orthodox medicine; lately it is often perplexed and exchangeable with the likes of 'avoid', and used all too commonly with implications meant to blur. You can now find to avoid Breast Cancer with 'Chemoprevention', a good program, but an irony in expression that has no shame.
20
October is Breast Cancer Awareness Month, and while it is critically important to raise awareness of breast cancer prevention in general; it is also a particularly important time for us ALL -- whether we are physicians, research scientists, women, or men -- to become acutely aware of a relatively rare, but all too often, poorly understood cancer known as Inflammatory Breast Cancer, or IBC.
Exercise may protect against both memory-loss and depressive mood after whole-brain radiation treatments, U.S. researchers say. The study, presented at the Society for Neuroscience annual meeting in Chicago, found mice with access to an exercise wheel less likely to suffer a decline in erasable memory after radiation and less likely to show depressive-like behavior.
Decades of studies have documented the link between eating a diet rich in vegetables and multiple health benefits, yet nearly eight out of 10 people worldwide fall short of the daily recommendation.(1) Research presented at the International Symposium on Human Health Effects of Fruits and Vegetables suggests the best approach may be to focus on the factors that are often behind this vegetable gap: convenience and enjoyment.
Warfarin, one of the most inconvenient, dangerous, and disliked drugs in the world, has remained vitally important for more than 50 years. That tells you how much difficulty scientists have had coming up with safer, easier pills to do what warfarin does -- fight life- threatening blood clots.
Prostate cancer is the most commonly diagnosed and second leading cause of cancer deaths in men in the United States. If detected early, prostate cancer treatment is highly successful, but at present there are no known treatments for advanced metastatic disease.
Lymphomas are the most common hematologic malignancies in the United States, accounting for up to 5% of all new cancer cases. As a group, they are the fifth leading cause of cancer deaths. Since the landmark report released in 1832 by Thomas Hodgkin, the classification of lymphomas has undergone repetitive adjustment, primarily a reflection of novel clinical and basic science discoveries.
We care about your feedback. Let us know how we can improve your CancerCompass experience.